DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Tannir N, Wong Y, Kollmannsberger C, Ernstoff MS, Perry DJ, Appleman LJ, Posadas E, Qian J, Ricker JL, Michaelson DM.
Phase II trial of ABT-869 in advanced renal cell cancer (RCC)
after sunitinib failure: Efficacy and safety results.
J Clin Oncol 2009; 27
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.